These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13533408)

  • 1. Complementfixing antigens of living and inactivated poliovirus. I. Complement-fixing antibody response of laboratory animals to poliovirus.
    HARE JD; WARREN J
    Am J Hyg; 1958 May; 67(3):350-66. PubMed ID: 13533408
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement-fixing antigens of living and inactivated poliovirus. II. Complement-fixing activity of poliomyelitis vaccine and its relation to immunogenic potency.
    WARREN J; HARE JD; GOLDMAN C
    Am J Public Health Nations Health; 1959 Jan; 49(1):53-61. PubMed ID: 13617534
    [No Abstract]   [Full Text] [Related]  

  • 3. Appearance of soluble and cross-reactive complement-fixing antigens on treatment of poliovirus with formalin.
    BLACK FL; MELNICK JL
    Proc Soc Exp Biol Med; 1955 Jul; 89(3):353-5. PubMed ID: 13254758
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the complement-fixing antibody response to poliovirus in patients with certain Coxsackie and ECHO virus infections.
    LENNETTE EH; SCHMIDT NJ; MAGOFFIN RL
    J Immunol; 1961 May; 86():552-60. PubMed ID: 13760855
    [No Abstract]   [Full Text] [Related]  

  • 5. Complement-fixing antigens of live and inactivated poliovirus. III. Evaluation of a sensitive quantitative procedure for complement fixation.
    HARE JD; WARREN J
    Am J Hyg; 1958 Nov; 68(3):312-21. PubMed ID: 13594931
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses.
    EGGERS HJ; SABIN AB
    Arch Gesamte Virusforsch; 1961; 11():152-75. PubMed ID: 13725917
    [No Abstract]   [Full Text] [Related]  

  • 7. Poliovirus as an antigen.
    STEVENS KM
    J Hyg (Lond); 1957 Dec; 55(4):489-93. PubMed ID: 13491837
    [No Abstract]   [Full Text] [Related]  

  • 8. The measurement of the D-antigen in poliovirus preparations.
    BEALE AJ; MASON PJ
    J Hyg (Lond); 1962 Mar; 60(1):113-21. PubMed ID: 13866112
    [No Abstract]   [Full Text] [Related]  

  • 9. The behavior of different strains of poliomyelitis virus in the complement fixation reaction. III. Comparison of the potency of complement fixing antigens derived from different strains of poliomyelitis virus.
    SCHMIDT NJ; LENNETTE EH; DENNIS J; HAGENS SJ
    J Immunol; 1960 Jul; 85():67-71. PubMed ID: 14443080
    [No Abstract]   [Full Text] [Related]  

  • 10. Immuno-inactivation of poliovirus.
    GARD S
    Arch Gesamte Virusforsch; 1957; 7(5):449-60. PubMed ID: 13521959
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement fixing antibodies in guinea pigs after inoculation of poliovirus antigens.
    PAPAPANAGIOTOU J; VON MAGNUS H
    Acta Pathol Microbiol Scand; 1962; 54():99-106. PubMed ID: 14483691
    [No Abstract]   [Full Text] [Related]  

  • 12. [SEROLOGICAL SURVEY OF CHILDREN FOR ANTIBODIES TO POLIOMYELITIS VIRUSES IN MOSCOW IN 1962].
    VOROSHILOVA MK; TARANOVA GP; EMELIANENKOVA VP; SHCHEGLOVA AP; KAPLAN SB
    Vopr Virusol; 1963; 29():404-9. PubMed ID: 14071275
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antibody production against poliovirus N and H antigens by immunization of guinea pigs].
    Mietens C; Fuhrmeister U
    Arch Gesamte Virusforsch; 1971; 34(1):23-31. PubMed ID: 4329437
    [No Abstract]   [Full Text] [Related]  

  • 14. The D to C change in poliovirus particles.
    LE BOUVIER GL
    Br J Exp Pathol; 1959 Dec; 40(6):605-20. PubMed ID: 14414843
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the complement-fixing antigens of poliomyelitis. III. Intracellular development of antigen.
    HINUMA Y; HUMMELER K
    J Immunol; 1961 Oct; 87():367-75. PubMed ID: 13907581
    [No Abstract]   [Full Text] [Related]  

  • 16. The adaptation of poliomyelitis virus, Lansing strain, to newborn mice and the use of their central nervous tissues for preparation of complement-fixing antigen.
    CASALS J; OLITSKY PK
    Arch Gesamte Virusforsch; 1951; 4(4):452-9. PubMed ID: 13249481
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antibody response to a vaccination against polio virus during treatment with isonicotinic acid hydrazide].
    PITZURRA M; CUSMA N; BISCATTI O; DONATI M
    Boll Soc Ital Biol Sper; 1962 Feb; 38():130-2. PubMed ID: 14487009
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of complement-fixing antigens by types 1 and 2 poliomyelitis-infected suckling mouse brains.
    SELZER G
    J Hyg (Lond); 1959 Sep; 57(3):321-5. PubMed ID: 14444802
    [No Abstract]   [Full Text] [Related]  

  • 19. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the preparation of complement fixing polio antigens.
    PAPAPANAGIOTOU J
    Acta Pathol Microbiol Scand; 1961; 53():280-92. PubMed ID: 14483692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.